Social determinants of health (SDOH) have a significant impact on well-being and quality of life. They also contribute to long-standing health disparities and inequities. As digital health solutions become widely embraced, employers and providers have both an opportunity and responsibility to leverage technology and human-centered care to remove these barriers at scale. Join this engaging conversation to learn how Sword and Quantum Health are working together to improve access to care for historically underserved populations.

Panelists

Dr. Ashley Bass photo
Dr. Ashley Bass
Health Equity and Inclusion Specialist
Sword Health
Dr. Dana Andrews photo
Dr. Dana Andrews
Chief Medical Officer
Quantum Health

Recorded on

September 14, 2023

Duration

40 minutes

Watch the webinar

Watch on-demand

More like this

Vida and Quantum Health logo
Webinar

Managing GLP-1 Costs Without Compromising Outcomes

GLP-1 medications continue to surge in popularity, offering effective solutions for weight management, Type 2 diabetes, and other emerging indications. While these drugs show significant clinical benefits, their skyrocketing costs present a major challenge for self-insured employers. Current solutions fall short at addressing the core issue: ensuring members have access to these medications when appropriate while supporting long-term health and sustainable cost management.

Learn more
Enhancing Member Confidence and Retention in Medicare Advantage: The Power of Proactive Navigation
Webinar

Enhancing Member Confidence and Retention in Medicare Advantage: The Power of Proactive Navigation

Watch our partnered webinar with RISE, as we share thought leadership on the latest strategies for enhancing member experience, improving satisfaction, and closing care gaps.

Learn more
Pharmacy Webinar Series-green
Webinar

Balancing the Clinical Benefits and Cost of GLP-1s

Join us for an in-depth look at GLP-1 medications, including how they work, why they’re so popular, and the risks associated with taking them. Together we’ll explore strategies to help employers manage the use of these drugs within their benefits plan while also examining medical trends associated with GLP-1s. You’ll leave with insights to help set your organization up for long-term success, both clinically and financially.

Learn more